Epirus and Orygen strike biosimilar deal in Brazil

Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados and the San Diego office of Latham & Watkins LLP has helped the Swiss subsidiary of Boston-based Epirus Biopharmaceuticals enter into a collaborative agreement with Orygen Biotecnologia, bringing the biosimilar producer’s technology to the Brazilian medical market.

Unlock unlimited access to all Latin Lawyer content